Aston Martin Lagonda Q3 Loss Widens

British sports cars maker, Aston Martin Lagonda Global Holdings plc (AML.L), on Thursday posted a wider loss for the third quarter, impacted by planned ramp up of St Athan, despite a surge in revenue driven by strong customer demand.

The Group's loss before tax widened to 97.9 million pounds from 80.5 million pounds, and loss per share increased to 77.6 pence from 77.4 pence last year.

However, luxury car group's operating loss for the period was reduced to 30.2 million pounds from last year's 69.8 million pounds.

On an adjusted basis, loss before tax widened to 95.7 million pounds from 80.4 million pounds, but loss per share decreased to 76.1 pence from 77.5 pence last year.

The Group's revenue for the third quarter rose to 237.6 million pounds from 124 million pounds, with strong growth in wholesales.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Covid vaccine makers Pfizer Inc. and BioNTech SE announced a new $3.2 billion vaccine supply deal with the U.S. Government, as the country is bracing for a Covid outbreak this fall. Under the deal, the U.S. government will receive 105 million doses (30 µg, 10 µg and 3 µg) of Pfizer -BioNTech covid vaccines initially. The order may include adult Omicron-adapted COVID-19 vaccines. Samsung Electronics Co. has started the initial mass production of 3-nanometer or nm chips, which is considered as the most advanced chip in the world. In its move, the South Korean tech major beats rival Taiwan Semiconductor Manufacturing Co., the world's largest chip manufacturer, which is reportedly in the process to build one. Bryant Ranch Prepack Inc. is recalling certain Morphine Sulfate Extended-Release Tablets citing incorrect labeling, the U.S. Food and Drug Administration said. The recall involves one lot of Morphine Sulfate 30 mg Extended-Release tablets, and one lot of Morphine Sulfate 60 mg Extended-Release tablets to the consumer level.
Follow RTT